NCT02106416View on ClinicalTrials.gov

Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Prostate CancerBladder Cancer
Interventions
PROCEDURE

PET/MRI

Simultaneous PET/MRI (3T system)

Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02106416 - Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development | Biotech Hunter | Biotech Hunter